Related Experiment Video
Updated: May 18, 2026
10:33
Exploring the Two Herb Combination Strategy to Treat Injured PC12 Cells
Published on: November 18, 2022
Alpha- and beta-asarone in herbal medicinal products. A case study
Dariusz Zuba1, Bogumiła Byrska
1Institute of Forensic Research, Westerplatte 9, 31 033 Kraków, Poland. dzuba@ies.krakow.pl
Forensic Science International
|September 12, 2012
Summary
Analysis of seized Chinese natural medicine revealed high levels of asarone isomers in pellets and tablets. Most products exceeded the maximum daily intake, posing potential health risks due to toxic compound concentrations.
Area of Science:
- Pharmacology
- Analytical Chemistry
- Toxicology
Background:
- Chinese natural medicines are popular but require rigorous quality control.
- Concerns arose regarding the safety of certain preparations following a reported intoxication incident.
- Asarone isomers are known toxic compounds found in some traditional herbs.
Purpose of the Study:
- To determine the chemical composition of seized Chinese natural medicine products.
- To quantify the levels of alpha- and beta-asarone isomers in these preparations.
- To assess the potential health risks associated with the consumption of these products.
Main Methods:
- Gas Chromatography-Mass Spectrometry (GC-MS) using an HP-5 ms column.
- High-Performance Liquid Chromatography (HPLC) with a Chromolith® monolithic column.
- Quantitative analysis of asarone isomer content in pellets and tablets.
Main Results:
- Significant variation in alpha- and beta-asarone content was observed across samples.
- Alpha-asarone doses ranged from 0.49 to 42.5 μg/pellet and averaged 51.4 μg in tablets.
- Beta-asarone was detected at high levels (142-645 μg/pellet, average 1526 μg in tablets), especially in samples with higher alpha-asarone.
- Total asarone content in most samples exceeded the 115 μg maximum acceptable daily intake.
Conclusions:
- The studied Chinese natural medicine preparations contain potentially health-threatening levels of asarone isomers.
- Exceedance of the maximum acceptable daily intake is likely with recommended dosages.
- Urgent regulatory review and quality control measures are needed for such products.
Related Concept Videos
01:28Structure-Activity Relationships and Drug Design
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
01:17Adrenergic Antagonists: Chemistry and Classification of ɑ-Receptor Blockers
Adrenergic antagonists, or sympatholytics, inhibit adrenoceptor activation driven by catecholamines or agonists. Based on their adrenoceptor specificity, adrenergic blockers can be categorized into two primary groups: α-adrenergic blockers (α-blockers) and β-adrenergic blockers (β-blockers). α-blockers interact with α1 and α2 subtypes of α-adrenoceptors.
Nonselective α-blockers: Nonselective α-blockers contain haloalkylamine or imidazoline moieties. Phenoxybenzamine, with a haloalkylamine...
Nonselective α-blockers: Nonselective α-blockers contain haloalkylamine or imidazoline moieties. Phenoxybenzamine, with a haloalkylamine...
01:28Antihypertensive Drugs: Types of β-Blockers
β receptors are classified into three subclasses: β1, β2, and β3. β1 receptors are primarily located in the heart and kidneys. When they get activated, they increase heart rate, contractility, and renin release. This process enhances blood pressure and aids in stress management. In contrast, β2 receptors are situated mainly in the lungs, blood vessels, and skeletal muscles. Upon activation, they trigger smooth muscle relaxation, causing bronchodilation and vasodilation. This widens airways and...
01:17Antihypertensive Drugs: Action of β1 Blockers
β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this, β1-blockers...
01:25Antiasthma Drugs: β2-Adrenoceptor Agonists
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce relaxation in these...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce relaxation in these...
01:22Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers
α-Adrenergic antagonists, known as α-blockers, exert their effects by inhibiting α-adrenoceptors, leading to specific physiological actions. α1-blockers and α2-blockers have distinct pharmacological actions and therapeutic applications.
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally, α1-blockers effectively address urinary obstruction...
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally, α1-blockers effectively address urinary obstruction...